Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pharma and Biotech Professionals of CEE Getting Together for Further Industry Growth in the Region

Published: Friday, January 18, 2013
Last Updated: Friday, January 18, 2013
Bookmark and Share
PHARM Connect Congress has been established to facilitate the collaboration and development of the most important pharma and biotech players.

Central and Eastern Europe is a rapidly emerging market for pharmaceutical manufacturing and distribution, and at the same time countries of the region are becoming hot-spots for research with many universities, research institutes and biotechnology companies being present. On the other hand, companies in the pharmaceutical sector face challenges that are not encountered in any other, from healthcare reforms to changing regulations. It is clear that in these sectors the constant search for effective and innovative partnerships as well as continuous professional development and market-specific knowledge are more important than in any other field.

Responding to the demand of a growing industry with exceptionally specific needs, the annual PHARM Connect Congress has been established to facilitate the collaboration and development of the most important pharma and biotech players in the emerging and strategically important region of CEE. On 27-28 February, the most prominent professionals and the key solution providers will gather in the five-star Corinthia Grand Hotel Royal in Budapest for the third time, to discuss challenges and start new collaborations at the market-leading pharmaceutical event. With its unique format that combines professional development and effective networking, PHARM Connect is supported by all major associations and governmental ministries, who agree that the congress has developed itself into a much needed platform for further industry growth in the region.

From OPEX to logistics: the most up-to-date topics

The conference programme will cover a wide range of topics from operational excellence (Prof. Dr. Thomas Friedli from the University of St. Gallen in Switzerland) and new logistics strategies (Zoltán Kelemen, CEE Business Development Manager of Phoenix Pharma) to the new EU Pharmacovigilance legislations (Amer Alghabban, Director of Gobal Quality Assurance & Auditing at Merck). Martin Fitzgerald, Deputy Director General of the European Association of Pharmaceutical Full-line Wholesalers will explain the impact of medicines verification systems on today’s pharmaceutical supply chain, giving ideas on developing a cost-effective solution for medicines verification in Europe. The future of personalized medicines will be addressed by Dr. István Peták and Dr. Richárd Schwab, Scientific and Medical Directors of KPS Diagnostics, who will share their valuable ideas on how to make biosimilars and diagnostics more affordable. Other speakers include Dr. Zsolt Szombathelyi, the Global Research Director of Gedeon Richter, who will talk about keeping the R&D pipeline innovative and Prof. Dr. Tamás L. Paál, the Senior Adviser of GYEMSZI as the Chairman of the first day. The programme was put together with the help of a renowned advisory committee to make sure that all areas of pharmaceutical production and distribution – from R&D and quality to purchasing and logistics - are covered. As Dr. Jens Scheibner, the Executive Director of Operations Biberach at Boehringer Ingelheim put it: “the most important and up-to-date topics are covered, exactly the way it should be.“

Effective networking is the key to success

The conference is only one part of the secret recipe that makes PHARM Connect the market-leading event in CEE. During the two days the most important solution providers will exhibit their innovative products; moreover, they will host pre-scheduled one-to-one meetings with key decision makers attending the event. This is the point where one can clearly distinguish networking and effective networking: face-to-face meetings that were mutually agreed on prior to the event guarantee that delegates will be in a position to discuss their own needs based on the current and future projects within their companies. Over 30 vendors will be represented covering a wide scope of solutions from automation, APIs, lab equipment to warehousing, logistics and beyond – Aptar Pharma, Cemelog, GE Intelligent Platforms, DHL, Evonik, Festo, Fette, Phoenix Pharma, Sartorius, Menadiona, Bosch Packaging, ABB,  just to mention a few – assuring that everyone finds what they are looking for.

PHARM Connect will bring together over 500 key decision-makers of the most important pharmaceutical and biotechnology companies from at least 20 different countries of the region for two days to provide them with a platform where they can learn from their most respected peers, immerse themselves in an environment where everyone is talking about their day-to-day challenges and find solutions to them via effective meetings. The professional atmosphere will be complemented by more informal networking opportunities – like a plant excursion to the GSK Biologicals plant and a cocktail reception on the first evening – making PHARM Connect not only a truly beneficial event, but an enjoyable one as well.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!